| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 361,027 | 373,108 | 335,300 | 347,336 | | Cost of Revenue | 97,307 | 95,069 | 83,009 | 76,681 | | | Gross Profit | 263,720 | 278,039 | 252,291 | 270,655 | | | Operating Expenses | | Research Development | 59,690 | 48,508 | 28,414 | 27,967 | | Selling General and Administrative | 139,922 | 103,187 | 146,411 | 130,288 | | Non Recurring | (20,206) | 61,428 |
-
| (530) | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 84,314 | 64,916 | 77,466 | 112,930 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 3,024 | 2,570 | 35 | 1,785 | | Earnings Before Interest And Taxes | 87,338 | 67,486 | 77,501 | 114,715 | | Interest Expense | 8,009 | 11,471 | 8,733 | 2,805 | | Income Before Tax | 79,329 | 56,015 | 68,768 | 111,910 | | Income Tax Expense | 29,907 | 25,986 | 29,731 | 36,968 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 49,422 | 30,029 | 39,037 | 74,942 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 49,422 | 30,029 | 39,037 | 74,942 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $49,422 | $30,029 | $39,037 | $74,942 |
|
0.29% Nasdaq 
Income Statement
